Clinical Research Group Sp. z o.o.
About Clinical Research Group Sp. z o.o.
"CRG to jeden z wiodących ośrodków badań klinicznych w Polsce, realizujący najwyższej jakości badania kliniczne faz II i III. Jesteśmy ogniwem łączącym pacjenta z najnowszymi osiągnięciami medycyny, a dzięki współpracy z czołowymi przedstawicielami branży farmaceutycznej razem dążymy do poprawy jakości życia ludzi na całym świecie."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
3
Bristol-Myers Squibb
2
Adial Pharmaceuticals
1
Akros Pharma Inc.
1
AnaptysBio, Inc.
1
Galapagos NV
1
UNION therapeutics
1
Clinical Trials at Clinical Research Group Sp. z o.o.
During the past decade, Clinical Research Group Sp. z o.o. conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Investigating the Efficacy, Safety, and PK Profile of ANB020 Administered to Adult Subjects With Moderate-to-Severe AD
2018-05-23
2019-09-01
Unknown status
300
A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Subjects With Moderate to Severe Atopic Dermatitis
2018-04-26
2020-03-03
Terminated
207
Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis
2018-08-07
2020-09-02
Completed
666
Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis
2019-01-17
2020-03-13
Completed
152
Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis
2019-08-12
2026-07-26
Active, not recruiting
1,452
Study to Evaluate AD04 in Adults With Alcohol Use Disorder (AUD) and Selected Serotonin Transporter Polymorphisms
2020-02-01
2022-03-18
Completed
302
Evaluation of the Efficacy and Safety of Lebrikizumab (LY3650150) in Moderate to Severe Atopic Dermatitis (ADvocate1)
2019-09-24
2022-05-03
Completed
424
Safety and Efficacy of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroid in Moderate-to-Severe Atopic Dermatitis.
2020-02-03
2021-09-16
Completed
228
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Clinical Research Group Sp. z o.o." #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Bristol-Myers Squibb" with 2 trials
sponsored, "Adial Pharmaceuticals" with 1 trials sponsored, "Akros Pharma Inc." with 1 trials sponsored and "AnaptysBio, Inc."
with 1 trials sponsored. Other sponsors include -3 different institutions and
companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Group Sp. z o.o."
#1 collaborator was "Dermira, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Clinical Research Group Sp. z o.o.
According to Clinical.Site data, the most researched conditions in "Clinical Research Group Sp. z o.o." are
"Atopic Dermatitis" (6 trials), "Psoriasis" (3 trials), "Skin Diseases" (2 trials), "Alcohol Use Disorder" (1 trials) and "Plaque Psoriasis" (1 trials). Many other conditions were trialed in "Clinical Research Group Sp. z o.o." in a lesser frequency.
Clinical Trials Intervention Types at Clinical Research Group Sp. z o.o.
Most popular intervention types in "Clinical Research Group Sp. z o.o." are "Drug" (7 trials), "Biological" (4 trials), "Other" (3 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (6 trials), "Lebrikizumab" (3 trials), "BMS-986165" (2 trials), "AD04 (ondansetron)" (1 trials) and "Apremilast" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clinical Research Group Sp. z o.o.
The vast majority of trials in "Clinical Research Group Sp. z o.o." are
10 trials for "All" genders.
Clinical Trials Status at Clinical Research Group Sp. z o.o.
Currently, there are NaN active trials in "Clinical Research Group Sp. z o.o.".
undefined are not yet recruiting,
1 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Clinical Research Group Sp. z o.o.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Research Group Sp. z o.o., 0 "Phase 1"
clinical trials were conducted, 4 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".